Tag: vaccine manufacturing

First messenger RNA influenza vaccine outperforms standard-dose vaccination

byDeepti Shroff

September 15, 2026

1. mFlusiva is the first messenger RNA influenza vaccine approved in the United States, with the FLUENT phase 3 trial ...

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

First messenger RNA influenza vaccine outperforms standard-dose vaccination
Few interventions improve posthospitalization follow-up for alcohol use disorder
Borderline-low hemoglobin levels linked to increased mortality

No Result

View All Result

Tag: vaccine manufacturing

First messenger RNA influenza vaccine outperforms standard-dose vaccination

2MM+ All Access

Recent Reports

The medical literature, distilled daily.

Membership benefits